CD4 Lymphocyte Count as a Predictor of the Duration of Highly Active Antiretroviral Therapy–Induced Suppression of Human ImmunodeficiencyVirus Load-Reference-Cited by-同舟云学术

CD4 Lymphocyte Count as a Predictor of the Duration of Highly Active Antiretroviral Therapy–Induced Suppression of Human ImmunodeficiencyVirus Load

Published:1999-08 Issue:2 Volume:180 Page:530-533
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:J INFECT DIS

Author:

Miller Veronica,Staszewski Schlomo,Sabin Caroline,Carlebach Amina,Rottmann Carsten,Weidmann Eckhart,Rabenau Holger,Hill Andrew,Cozzi Lepri Alessandro,Phillips Andrew N.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/180/2/530/17994838/180-2-530.pdf

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A characterization of the HIV population with limited/exhausted treatment options: a multicenter Belgian study;Acta Clinica Belgica;2024-05-03

2. Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients;AIDS;2020-04-13

3. Efficacy and safety of lopinavir/ritonavir-based antiretroviral therapy in HIV-1-infected subjects with advanced disease: a systematic review and meta-analysis;Future Virology;2015-08

4. Guidelines for organizing national external quality assessment scheme for performing CD4+ T-lymphocyte determinations in persons infected with HIV in resource-limited settings;Accreditation and Quality Assurance;2015-07-11

5. Low-CD4+ T-lymphocyte blood samples for external quality assessment of CD4 testing in resource-poor settings;Accreditation and Quality Assurance;2014-11-02